Effect of Pindolol on the Function of Pre- and Postsynaptic 5-HT1A Receptors: In Vivo Microdialysis and Electrophysiological Studies in the Rat Brain

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Neuropsychopharmacology

• Publication date

  1996-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0893-133X(95)00240-EPMID 8887989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacology of the hypothermic response to 5-HT1A receptor activation in humans

  2007cited by this paper
• Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: Single-cell studies in the rat

  2004cited by this paper
• Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

  1995cited by this paper
• Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo.

  1995cited by this paper
• Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.

  1994cited by this paper
• Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus.

  1994cited by this paper
• Desensitization of the neuronal 5-HT carrier following its long-term blockade

  1994cited by this paper
• Current advances and trends in the treatment of depression.

  1994cited by this paper
• Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)

  1994cited by this paper
• 5-hydroxytryptamine1 recognition sites in rat brain: heterogeneity of non-5-hydroxytryptamine1A/1C binding sites revealed by quantitative receptor autoradiography.

  1993cited by this paper
• 5-HT and antidepressants: new views from microdialysis studies.

  1993cited by this paper
• Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei

  1993cited by this paper
• Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.

  1993cited by this paper
• In Vivo Brain Dialysis Study of the Somatodendritic Release of Serotonin in the Raphe Nuclei of the Rat: Effects of 8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin

  1993cited by this paper
• Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat

  1993cited by this paper
• Serotonin 5‐HT1A Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis Study

  1993cited by this paper
• Stereoselective inhibition of pindolol renal clearance by cimetidine in humans

  1992cited by this paper
• Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

  1992cited by this paper
• Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study.

  1992cited by this paper
• Administration of 8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin in Raphe Nuclei Dorsalis and Medianus Reduces Serotonin Synthesis in the Rat Brain: Differences in Potency and Regional Sensitivity

  1991cited by this paper
• 5-HT receptors: subtypes and second messengers.

  1991cited by this paper
• Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.

  1991cited by this paper
• Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.

  1991cited by this paper
• The role of serotonin release and autoreceptors in the dorsalis raphe nucleus in the control of serotonin release in the cat caudate nucleus.

  1990cited by this paper
• Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.

  1990cited by this paper
• Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat

  1990cited by this paper
• Differential responsiveness of the rat dorsal and median raphe 5‐HT systems to 5‐HT1 receptor agonists and p‐chloroamphetamine

  1990cited by this paper
• Serotonin 5-HT3, 5-HT4, and 5-HT-M receptors.

  1990cited by this paper
• Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis.

  1989cited by this paper
• 5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis

  1989cited by this paper
• Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat.

  1988cited by this paper
• Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons.

  1988cited by this paper
• Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor.

  1988cited by this paper
• Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine.

  1988cited by this paper
• Effects of the 5-hydroxytryptamine receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system.

  1988cited by this paper
• Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain

  1987cited by this paper
• Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists

  1987cited by this paper
• Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons.

  1987cited by this paper
• The organization of divergent axonal projections from the midbrain raphe nuclei in the rat

  1986cited by this paper
• β-Adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain

  1985cited by this paper
• Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.

  1985cited by this paper
• Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment.

  1984cited by this paper
• Hyperpolarization of serotonergic neurons by serotonin and LSD: studies in brain slices showing increased K+ conductance.

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• In vivo release of serotonin in two raphe nuclei (raphe dorsalis and magnus) of the cat.

  1982cited by this paper
• Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants; Correlation with reduction of spontaneous firing rate of central monoaminergic neurones

  1982cited by this paper
• Control of 5-HT release in the caudate nucleus and the substantia nigra of the cat.

  1981cited by this paper
• An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat

  1978cited by this paper
• Raphe neurons: effect of tricyclic antidepressant drugs

  1972cited by this paper
• Electrophysiology of hippocampal neurons. II. After-potentials and repetitive firing.

  1961cited by this paper

• Pathway-selective 5-HT1AR agonist as a rapid antidepressant strategy.

  2025cites this paper
• Dissecting the contribution of 5-HT1A auto- and heteroreceptors in sucrose overconsumption in mice.

  2022cites this paper
• Antidepressant Drug Sertraline against Human Cancer Cells

  2022cites this paper
• Median raphe serotonergic neurons projecting to the interpeduncular nucleus control preference and aversion

  2022cites this paper
• 5-HT Receptors and the Development of New Antidepressants

  2021cites this paper
• Role of central serotonin and noradrenaline interactions in the antidepressants' action: Electrophysiological and neurochemical evidence.

  2021cites this paper
• The Antidepressant Sertraline Reduces Synaptic Transmission Efficacy and Synaptogenesis Between Identified Lymnaea Neurons

  2020cites this paper
• Delayed Antidepressant Efficacy and the Desensitization Hypothesis.

  2019cites this paper
• Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge

  2019cites this paper
• Role of hippocampal 5‐HT1A receptors in the antidepressant‐like phenotype of mice expressing RGS‐insensitive G&agr;i2 protein

  2018cites this paper
• Melanin-Concentrating Hormone and Sleep

  2018cites this paper
• Drugs which influence serotonin transporter and serotonergic receptors: Pharmacological and clinical properties in the treatment of depression

  2018cites this paper
• MCH and Depression

  2018cites this paper
• TREATING OBESITY AND FOOD CRAVING

  2017cites this paper
• Effect of Physical Exercise and Acute Escitalopram on the Excitability of Brain Monoamine Neurons: In Vivo Electrophysiological Study in Rats

  2017cites this paper
• Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies.

  2017cites this paper
• Managing epilepsy-associated depression: Serotonin enhancers or serotonin producers?

  2017cites this paper
• Associations between cognition and serotonin receptor 1B binding in patients with major depressive disorder - A pilot study.

  2017cites this paper
• 3.09 – Aldosterone Action on Brain and Behavior

  2017cites this paper
• 9. Adrenergic Agents

  2017cites this paper
• Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale.

  2016cites this paper
• PACAP and Depression

  2016cites this paper
• Impact of Depressogenic-and Antidepressant-like Challenges on Monoamine System Activities: in vivo Electrophysiological Characterization Studies

  2016cites this paper
• Understanding the impact of 5-HTTLPR, antidepressants, and acute tryptophan depletion on brain activation during facial emotion processing: A review of the imaging literature.

  2016cites this paper
• The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder

  2016cites this paper
• Looking back (and in)to the future: A personal reflection on ‘Serotonin autoreceptor function and antidepressant drug action’ (Hjorth et al., 2000)

  2016cites this paper
• The Discovery of the Antidepressant Vortioxetine and the Research that Uncovered Its Potential to Treat the Cognitive Dysfunction Associated with Depression

  2016cites this paper
• Developments in the field of antidepressants, where do we go now?

  2015cites this paper
• Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta‐analysis

  2015cites this paper
• Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions at serotonin receptors may enhance downstream release of four pro-cognitive neurotransmitters

  2015cites this paper
• Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors)

  2015cites this paper
• Serotonin and exercise-induced brain plasticity

  2015cites this paper
• Long-term administration of the antidepressant vilazodone modulates rat brain monoaminergic systems.

  2015cites this paper
• The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

  2015cites this paper
• Changes in Intensity of Serotonin Syndrome Caused by Adverse Interaction between Monoamine Oxidase Inhibitors and Serotonin Reuptake Blockers

  2014cites this paper
• The role of different serotonin receptor subtypes in seizure susceptibility

  2014cites this paper
• Upregulation of the dorsal raphe nucleus-prefrontal cortex serotonin system by chronic treatment with escitalopram in hyposerotonergic Wistar-Kyoto rats.

  2013cites this paper
• Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain.

  2013cites this paper
• Serotonin receptors involved in antidepressant effects.

  2013cites this paper
• Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

  2012cites this paper
• Translatability scoring in drug development: eight case studies

  2012cites this paper
• Both acute and subchronic treatments with pindolol, a 5-HT(1A) and β₁ and β₂ adrenoceptor antagonist, elevate regional serotonin synthesis in the rat brain: an autoradiographic study.

  2012cites this paper
• Preclinical and clinical characterization of the selective 5‐HT1A receptor antagonist DU‐125530 for antidepressant treatment

  2012cites this paper
• Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.

  2011cites this paper
• Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze.

  2011cites this paper
• Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study.

  2010cites this paper
• Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.

  2009influential citation
• Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.

  2009cites this paper
• Apamin increases 5-HT cell firing in raphe dorsalis and extracellular 5-HT levels in amygdala: a concomitant in vivo study in anesthetized rats.

  2009cites this paper
• The role of pharmacogenetics in the treatment of depression and anxiety disorders

  2009cites this paper
• Isoflurane anesthesia inhibits clozapine- and risperidone-induced dopamine release and anesthesia-induced changes in dopamine metabolism was modified by fluoxetine in the rat striatum: an in vivo microdialysis study.

  2008cites this paper
• Serotonergic Neurons of Dorsal Raphe Nucleus on the Effect of a Xanthone from Kielmeyera coriacea Stems in Behavioral Tests

  2008cites this paper
• WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality.

  2008cites this paper
• 5-HT-1A Receptor

  2008cites this paper
• 5-HT1 receptor augmentation strategies as enhanced efficacy: therapeutics for psychiatric disorders.

  2008cites this paper
• In vivo electrophysiological assessment of the putative antidepressant Wf-516 in the rat raphe dorsalis, locus coeruleus and hippocampus

  2007cites this paper
• Role of 5-HT 1A receptors in antidepressant-like effect of dichloromethane fraction of Kielmeyera coriacea in rats subjected to the forced swim test

  2007cites this paper
• SB-649915-B, a Novel 5-HT1A/B Autoreceptor Antagonist and Serotonin Reuptake Inhibitor, is Anxiolytic and Displays Fast Onset Activity in the Rat High Light Social Interaction Test

  2007influential citation
• Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B

  2007influential citation
• Localization of the serotonergic terminal fields modulating seizures in the genetically epilepsy-prone rat.

  2007cites this paper
• Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonist.

  2006cites this paper
• Chapter 6.3 The use of brain microdialysis in antidepressant drug research

  2006cites this paper
• Pindolol augmentation of antidepressant response.

  2006cites this paper
• Blockade of 5-HT1A Receptors by (±)-Pindolol Potentiates Cortical 5-HT Outflow, but not Antidepressant-Like Activity of Paroxetine: Microdialysis and Behavioral Approaches in 5-HT1A Receptor Knockout Mice

  2006cites this paper
• Pindolol does not augment central serotonin function increases to citalopram in humans: an auditory evoked potential investigation.

  2006cites this paper
• Blockade of 5-HT 1 A Receptors by ( 7 )-Pindolol Potentiates Cortical 5-HT Outflow , but not Antidepressant-Like Activity of Paroxetine : Microdialysis and Behavioral Approaches in 5-HT 1 A Receptor Knockout Mice

  2006cites this paper
• Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol.

  2005cites this paper
• Pindolol augmentation of selective serotonin reuptake inhibitors: Accounting for the variability of results of placebo‐controlled double‐blind studies in patients with major depression

  2005cites this paper
• A Mathematical Model for Paroxetine Antidepressant Effect Time Course and Its Interaction with Pindolol

  2005cites this paper
• Effects of Acute and Long-Term Administration of Escitalopram and Citalopram on Serotonin Neurotransmission: an In Vivo Electrophysiological Study in Rat Brain

  2005cites this paper
• Paroxetine combined with a 5-HT1A receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats

  2005cites this paper
• Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.

  2005cites this paper
• Antidepressant treatment and rodent aggressive behaviour.

  2005cites this paper
• Allopregnanolone and ganaxolone increase the firing activity of dorsal raphe nucleus serotonergic neurons in female rats.

  2005cites this paper
• Akzeleration der Antidepressivaresponse und Augmentation mit Pindolol

  2005cites this paper
• Preferential 5-HT1A Autoreceptor Occupancy by Pindolol is Attenuated in Depressed Patients: Effect of Treatment or an Endophenotype of Depression?

  2004cites this paper
• The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.

  2004cites this paper
• Differential effects of (R)-, (R, S)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on hippocampal serotonin release and induction of hypothermia in awake rats.

  2004cites this paper
• The role of 5-hydroxytryptamine receptors in the control of micturition

  2004cites this paper
• Pharmacogenetics and Psychiatry

  2004cites this paper
• An autoradiographic study of the influence of pindolol upon [35S]GTPgammaS binding in rat, guinea pig and human brain.

  2004cites this paper
• Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects.

  2004cites this paper
• The pharmacology of putative early-onset antidepressant strategies.

  2003cites this paper
• Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers

  2003cites this paper
• Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities

  2003cites this paper
• Modulation of Serotonergic Function in Rat Brain by VN2222, a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist

  2003cites this paper
• Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future

  2003cites this paper
• Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity.

  2003cites this paper
• Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone.

  2003cites this paper
• The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats.

  2003cites this paper
• Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex.

  2003cites this paper
• Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial.

  2003cites this paper
• Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex

  2002cites this paper
• Behavioral and Neurochemical Effects of 5-{4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide (EMD 68843): A Combined Selective Inhibitor of Serotonin Reuptake and 5-Hydroxytryptamine1A Receptor Partial Agonist

  2002influential citation
• In vivo voltammetry and concomitant electrophysiology at a single micro-biosensor to analyse ischaemia, depression and drug dependence.

  2002cites this paper
• Serotonergic targets in depression.

  2002cites this paper
• Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study

  2002cites this paper
• Therapeutic potential of serotonin antagonists in depressive disorders

  2002cites this paper
• Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model.

  2002cites this paper
• An Overview of The Definition and Management of Treatment-Resistant Depression

  2002cites this paper